California Democrats Back $8.4 Billion Medical Research Initiative
Sacramento, Thursday, 6 August 2026.
The California Democratic Party endorsed Proposition 38, an $8.4 billion medical bond. Remarkably, half the funds are targeted for a single institute founded by a billionaire campaign donor.
Democratic Endorsement Secured for Medical Research Bond
On 5 August 2026, the California Democratic Party officially endorsed Proposition 38, a ballot measure designed to allocate $8.4 billion toward immunology and medical research [1]. This decision followed a vote by party delegates during the annual convention held on 1–2 August 2026, reflecting a strategic move to address uncertainties in federal research funding [1][3]. The initiative aims to direct substantial resources to public universities and nonprofit institutions for developing preventative treatments for chronic diseases such as cancer and Alzheimer’s [3]. By securing this endorsement, the campaign bolsters its coalition which includes over 50 organizations such as the ALS Association and the American Nurses Association California [3].
Funding Structure and Allocation Details
Proposition 38 proposes a total bond issuance of $8.4 billion, with specific stipulations on how the capital is deployed across the state [1]. According to analysis of the measure, $4 billion is earmarked for competitive grants, while the remaining $4 billion is restricted to an unnamed institute meeting specific criteria [5]. This allocation means that 47.619 of the total funding is effectively reserved for a single entity matching the description of the California Institute for Immunology and Immunotherapy [5]. The measure targets diseases including heart disease, neurodegenerative disorders, and autoimmune conditions, seeking to transform the state’s life sciences corridor [1].
Controversy Over Billionaire Backers
Critics argue that the structure of Proposition 38 disproportionately benefits billionaire backers involved in the initiative’s creation [2]. Reports indicate that the California Institute for Immunology and Immunotherapy was founded by billionaire Gary Michelson, who has contributed at least $8.2 million to the Yes on Proposition 38 campaign [5]. Additionally, co-founder Meyer Luskin has donated $5 million to support the measure, raising questions about the public return on private investment [5]. Observers note that half of the measure’s funding appears reserved for a single institution, a point of contention highlighted by political watchdogs [2].
Legislative Context and Upcoming Vote
The endorsement comes as California state lawmakers return to Sacramento for the final month of the legislative session, scheduled to conclude on 31 August 2026 [5]. Proposition 38 will appear on the ballot for voter approval in November 2026, requiring a majority vote to pass [5]. While the California Democratic Party has moved to support the measure, the broader legislative environment remains focused on climate funding and wildfire liability issues [5]. The outcome of the November vote will determine whether the $8.4 billion bond is issued to fund the proposed medical research initiatives [3].